Skip to content

Preventing Pain After Heart Surgery

CompletedPhase 4NCT01480765
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The use of pre-emptive analgesia to prevent pain following sternotomy for cardiac surgery

Study details

Official title
Prospective, Double-blinded, Randomised, Placebo Controlled Trial of Pre-emptive Analgesia to Prevent Pain Following Sternotomy for Cardiac Surgery.
Conditions
Interventions
  • Drug: Pregabalin
  • Drug: Ketamine infusion
  • Drug: Placebo capsules
  • Drug: Placebo infusion
Sponsor
Barts & The London NHS Trust
Start date
2011-12-12
Primary completion
2013-03-07
Sex
All
Age range
from 18 Years to 80 Years
Results posted
No results posted in this snapshot
Countries
United Kingdom
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Informed Consent * First time sternotomy for all cardiac surgery * Patient aged 18 - 80 years Exclusion Criteria: * Emergency surgery (decision to operate taken on the day of surgery) * Previous sternotomy * Preoperative renal failure (eGFR \<60 ml/min) * History of chronic non-anginal pain * Chronic pain medication other than paracetamol and non-steroidal anti-inflammatory drugs * Concurrent use of oxycodone, lorazepam, or ethanol. * Concurrent use of any drugs for neuropathic pain e.g. antiepileptics, antidepressants * Allergy to pregabalin, gabapentin or ketamine * Pregnancy * Limited understanding of numerical scoring scales * Previous participation in other trials investigating analgesic agents or any IMP in previous three months

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01480765